Imax Corporation (IMAX) Stock Price & How to Invest

IMAX Corporation designs and markets premium large-format cinema systems and licenses proprietary technology that lets studios remaster films into the IMAX format. Rather than owning most theaters itself, IMAX runs an asset-light model: it sells or leases its projection and sound systems to exhibitor partners, then earns ongoing revenue tied to ticket sales through revenue-share and joint-venture arrangements. Its two reporting segments are Technology Products and Services (the systems, maintenance, and network operations) and Content Solutions (film remastering, distribution, and the growing slate of local-language titles). By 2025 the IMAX network spanned more than 1,700 theaters globally, larger than rival premium formats.

The investment picture rests on premium cinema outperforming the broader box office as audiences pay up for a differentiated experience. In full-year 2025 IMAX reported best-ever revenue of about $410 million, up 16%, alongside a record global IMAX box office of roughly $1.28 billion and record cash from operations near $127 million. Growth drivers include an expanding local-language film slate (led by titles from China, Japan, and India), record system installations and signings, and margin expansion in Content Solutions. Offsetting these are the company's dependence on a strong Hollywood release calendar, a volatile Greater China market that dropped sharply in early 2026, rising competition from other premium formats, and a valuation that leaves little room for disappointment.

IMAX's results depend heavily on the theatrical film release calendar, which it does not control, so a weak slate of major titles in any period can pressure box office and revenue. Greater China is a swing market: IMAX box office there plunged roughly 62% in the first quarter of 2026 against a very strong prior-year period, showing how concentrated and volatile that geography can be. Competition from Dolby Cinema, Cinemark XD, Regal RPX, ScreenX, 4DX, and exhibitors' own premium-format brands is intensifying, and some operators resent the revenue cut IMAX takes. Longer term, the shift toward streaming and shorter theatrical windows could erode moviegoing, and at a trailing price-to-earnings multiple around 60x the stock prices in continued record performance, leaving it exposed if growth slows.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Imax Corporation's investor relations page or your broker.

• Revenue (FY2025): ~$410 million (+16%)
• Net income margin: ~11%
• Adjusted EBITDA margin: ~45% (record)
• Global IMAX box office (2025): ~$1.28 billion (record)
• Cash from operations: ~$127 million (+79%)
• Market cap: ~$2.2 billion
• P/E (trailing): ~60x
• 2026 box-office guidance: ~$1.4 billion

As of February 2026, IMAX reported best-ever full-year 2025 revenue of about $410 million with a net income margin near 11%, and the stock traded around the high $30s for a market cap near $2.2 billion. The trailing price-to-earnings multiple of roughly 60x is high relative to the broader market, reflecting expectations for continued record box office and network growth. The 2026 guidance of about $1.4 billion in global box office and 160 to 175 installations frames the growth the valuation assumes.

There are three common ways to get IMAX exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic basket, so IMAX sits alongside other stocks that express the same thesis.

Walnut takes the basket route. Describe a thesis where IMAX fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

IMAX is a niche, asset-light entertainment-technology company whose results ride the strength of the theatrical film slate and its own network expansion, and it trades at a rich earnings multiple that prices in continued record box office and installations.

Whether IMAX is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is IMAX a buy?, and where the stock could go from here in the IMAX stock forecast.

For income investors, whether IMAX pays a dividend and how the payout looks is covered in does IMAX pay a dividend?